<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03375385</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU R44/ 2017</org_study_id>
    <nct_id>NCT03375385</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Versus Propofol for Sedation in Stereotactic Brain Biopsy</brief_title>
  <official_title>Effect of Dexmedetomidine Versus Propofol on the Onset and Recovery of Sedation in Stereotactic Brain Biopsy A Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pre-operative anxiety leads to higher sympathetic stimulation. Propofol in the main drug used
      during interventional or imaging techniques that need sedation. Also, dexmedetomidine causes
      sedation, analgesia, sympatholytic properties, without respiratory depression.In stereotactic
      brain biopsy; patient discomfort due to drilling a hole through the skull and the advancement
      of the biopsy needle make the patient in need for good sedation and analgesia.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the sedation characteristics</measure>
    <time_frame>4 hours</time_frame>
    <description>Ramsay sedation score</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>the Sedation Characteristics of Propofol and Dexmedetomidine in Patients Undergoing Stereotactic Brain Biopsy</condition>
  <arm_group>
    <arm_group_label>Hemodynamic parameters</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ramsay sedation score</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Intraoperative side effects</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>recovery of sedation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine/ propofol</intervention_name>
    <description>The loading and infusion doses of dexmedetomidine hydrochloride and 1% propofol were calculated according to the patient's body weight and diluted to a 10 ml volume (labeled as loading-1 and loading-2) and a 50 ml volume (labeled as infusion-1 and infusion-2).</description>
    <arm_group_label>Hemodynamic parameters</arm_group_label>
    <arm_group_label>Ramsay sedation score</arm_group_label>
    <arm_group_label>Intraoperative side effects</arm_group_label>
    <arm_group_label>recovery of sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        Patients with:

          -  brain secondaries from the lung/breast/pancreas

          -  tuberculoma

          -  pyogenic abscess

          -  intra-axial supratentorial space occupying lesion with or without hydrocephalus *an
             average duration of the procedure 1- 2hr 30 min

          -  an available caregiver for overnight observation

          -  patient relative proximity to the hospital Exclusion criteria

        Patients with:

          -  morbid obesity (body mass index &gt;35 kg/m2)

          -  significant comorbidities (a known history of hepatic disease, renal dysfunction,
             hypertension, and chronic pain)

          -  history of drug or alcohol abuse

          -  an allergic reaction to one of the study medications

          -  anticipated difficult airway

          -  uncontrolled epilepsy

          -  poor neurological status

          -  neuropsychological unsuitability taking psychotropic drugs (benzodiazepines and
             barbiturates)

          -  patients with brain stem lesions (vital areas of brain)

          -  un-cooperative

          -  refusing adults

          -  patients with ventricular drain

          -  already inpatient

          -  Intubated patients and those who had a prior craniotomy .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2017</study_first_submitted>
  <study_first_submitted_qc>December 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 18, 2017</study_first_posted>
  <last_update_submitted>December 12, 2017</last_update_submitted>
  <last_update_submitted_qc>December 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ghada M.Samir</investigator_full_name>
    <investigator_title>assistant professor of anaesthesia and intensive care</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

